Jiadali (H.K.) Development Limited
⚠️ Moderate Risk
FEI: 3006563574 • North Point • HONG KONG
FEI Number
3006563574
Location
North Point
Country
HONG KONGAddress
No.9-23 Xian Road, Rm 17d, Xiuming, , North Point, , Hong Kong
Moderate Risk
FDA Import Risk Assessment
This firm has a moderate history of FDA import refusals. Some attention may be warranted.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
UNSAFE COL
The article appears to be, or to bear or contain a color additive which is unsafe within the meaning of Section 721(a).
Refusal History
Frequently Asked Questions
What is Jiadali (H.K.) Development Limited's FDA import refusal history?
Jiadali (H.K.) Development Limited (FEI: 3006563574) has 2 FDA import refusal record(s) in our database, spanning from 4/6/2011 to 4/6/2011.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Jiadali (H.K.) Development Limited's FEI number is 3006563574.
What types of violations has Jiadali (H.K.) Development Limited received?
Jiadali (H.K.) Development Limited has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Jiadali (H.K.) Development Limited come from?
All FDA import refusal data for Jiadali (H.K.) Development Limited is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.